Table 1 Patients characteristics (N=141)

From: Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survival

 

No. of patients

Percent

Age (years)

Median

56.6

 

Range

(30–84)

 

PS

<2

119

84%

2

23

16%

Receptor status

ER positive

102

72%

ER negative

39

27%

Her2/neu

Positive

26

19%

Negative

115

81%

Liver metastasis

Yes

54

36%

No

96

64%

Bone metastasis

Yes

56

40%

No

85

60%

Number of metastatic sites

4

124

88%

>4

17

12%

Lactate dehydrogenase

600

109

78%

>600

31

22%